Balloon kyphoplasty has been shown to benefit patients with osteoporotic or cancer-induced VCF. Pain, functional and radiographic outcomes of care have been shown to be statistically superior to conventional non-surgical management.
The procedure has been shown to significantly improve patient quality of life and ability to perform activities of daily living, as well as reduce the number of days lost to bedrest.
Balloon kyphoplasty is a percutaneous procedure that can be performed inpatient or outpatient with little or no postoperative rehabilitation necessary. Patient satisfaction with the technique is excellent with little, if any, procedural discomfort. Balloon kyphoplasty has an excellent safety profile, with most studies demonstrating a very low rate of procedure-related adverse events.
As of the end of the third quarter 2008, we have treated over 393,000 patients and 460,000 fractures worldwide with balloon kyphoplasty since we commercialized our products in 2000.
This achievement was made possible by the 12,800 spine specialists worldwide who are helping to establish balloon kyphoplasty as the standard of care for the treatment of vertebral compression fractures.
TOPICS IN THIS SECTION:
About the Procedure